| LRRK2 in Parkinson disease: challenges of clinical trials | Nature Reviews Neurology | 2020 | 130 |
| Statin therapy is associated with lower prevalence of gut microbiota dysbiosis | Nature | 2020 | 100 |
| Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations | Revue Neurologique | 2020 | 83 |
| Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase | Circulation | 2020 | 43 |
| Uses of pharmacovigilance databases: An overview | Therapie | 2020 | 37 |
| Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous? | Lancet, The | 2020 | 35 |
| Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019 | Clinical Gastroenterology and Hepatology | 2020 | 35 |
| Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment | Pharmacology & Therapeutics | 2020 | 33 |
| Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses | Arteriosclerosis, Thrombosis, and Vascular Biology | 2020 | 31 |
| Polysaccharide from Pimpinella anisum seeds: Structural characterization, anti-inflammatory and laser burn wound healing in mice | International Journal of Biological Macromolecules | 2020 | 24 |
| Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection | Antiviral Research | 2020 | 24 |
| Demographic Factors Associated with Toxicity in Patients Treated with Anti-Programmed Cell Death-1 Therapy | Cancer Immunology Research | 2020 | 20 |
| Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments | Fundamental and Clinical Pharmacology | 2020 | 19 |
| Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France | Therapie | 2020 | 18 |
| Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial | Journal of Antimicrobial Chemotherapy | 2020 | 18 |
| Ketamine and Magnesium for Refractory Neuropathic Pain: A Randomized, Double-blind, Crossover Trial | Anesthesiology | 2020 | 16 |
| Acute Coronary Syndrome With Immune Checkpoint Inhibitors: A Proof-of-Concept Case and Pharmacovigilance Analysis of a Life-Threatening Adverse Event | Canadian Journal of Cardiology | 2020 | 16 |
| Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19 | Antimicrobial Agents and Chemotherapy | 2020 | 16 |
| Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study | Archives of Cardiovascular Diseases | 2020 | 15 |
| In vitro flow based systems to study platelet function and thrombus formation: Recommendations for standardization: Communication from the SSC on Biorheology of the ISTH | Journal of Thrombosis and Haemostasis | 2020 | 15 |
| Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study | Neurobiology of Disease | 2020 | 13 |
| Inhaled levodopa in Parkinson's disease patients with OFF periods: A randomized 12-month pulmonary safety study | Parkinsonism and Related Disorders | 2020 | 13 |
| Pharmacogenetic-Whole blood and intracellular pharmacokinetic-Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients | PLoS ONE | 2020 | 12 |
| How to check whether a blood pressure monitor has been properly validated for accuracy | Journal of Clinical Hypertension | 2020 | 12 |
| Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review-An EAACI position paper | Allergy: European Journal of Allergy and Clinical Immunology | 2020 | 11 |
